JPRN-jRCT2080223781已完成1 期
Pharmacokinetic study of SK-1405 in subjects with or without hepatic impairment
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Capable of giving written consent to participate in the study from oneself
- •- BMI: equal to or more than 18.5, and less than 30.0 (exclusive); at the screening
- •- (Only in subjects with hepatic impairment) Diagnosed to have cirrhosis
排除标准
- •- Use of contraindicated drug
- •- History of surgery on digestive disease
- •- Mental disease
- •- Severe heart disease
- •- Severe allergy
- •- Complication or hisoty of drug dependence
- •- Habit of excessive drinking of alcohol
研究者
相似试验
已完成
1 期
Pharmacokinetic study of SK-1405 in patients undergoing hemodialysisJPRN-jRCT2080223782Sanwa Kagaku Kenkyusho Co., Ltd.12
未知
3 期
A clinical pharmacological study of SK-0403Type 2 diabetes mellitusJPRN-jRCT2080221260SANWA KAGAKU KENKYUSHO CO.,LTD.20
已完成
1 期
Pharmacokinetic study of K-877 in patients with Primary biliary cholangitisPrimary biliary cholangitisJPRN-jRCT2080223672Kowa Co., Ltd.8
未知
3 期
K-115 clinical pharmacology studyJPRN-jRCT2080221879Kowa Co., Ltd.30
进行中（未招募）
不适用
A Pilot Pharmacodynamic/Pharmacokinetic Study of SalmeterolXinofoate as a Dry Powder in Combination with Fluticasone in Patients with Asthma for Dose-Scale Bronchodilator Model Development.AsthmaMedDRA version: 12.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2010-018712-32-GBOriel Therapeutics Inc30